Quantcast

Latest Cancer Research Stories

2014-04-28 08:31:47

HACKENSACK, N.J., April 28, 2014 /PRNewswire/ -- Results from a study published in Clinical Cancer Research demonstrate that oncologists were able to accurately predict which therapies patients would respond to by using a combination of next-generation sequencing and drug sensitivity testing in mouse avatars (Champions TumorGrafts®) developed by Champions Oncology (OTC: CSBR). The paper, titled "Integrated Next Generation Sequencing and Avatar Mouse Models for Personalized Cancer...

3-D Printed Tumors Could Revolutionize Cancer Research
2014-04-26 06:12:21

Brett Smith for redOrbit.com - Your Universe Online For years, cancer-research scientists have been using two-dimensional petri dish models to study and test potential treatments. But now, a team of scientists led by Drexel University’s Wei Sun has developed a method for 3-D printing living tumors – a development that could revolutionize cancer research. According to a report on the development recently published the journal Biofabrication, the team was able to print out viable...

2014-04-24 08:34:02

Will oversee Virginia G. Piper Cancer Center's internationally recognized Phase I clinical trials program SCOTTSDALE, Ariz., April 24, 2014 /PRNewswire-USNewswire/ -- Michael S. Gordon, MD, one of the greater Phoenix area's leading medical oncologists and cancer researchers, has been named the new Medical Director for the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare. Dr. Gordon will oversee the center's internationally recognized Phase I clinical...

2014-04-24 08:33:57

Leading Cancer Immunotherapy Startup also Bolsters Leadership Team with Two Key Appointments SEATTLE, April 24, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, today announced the close of its Series A round with $176M in fully committed funds. http://photos.prnewswire.com/prnvar/20140113/DC45426LOGO Juno's initial funding of $120 million came predominantly from leading technology venture...

2014-04-18 13:44:32

The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. An analysis of prostate tissue biopsies collected from some participants of the placebo arm of the Prostate Cancer Prevention...

2014-04-18 12:13:08

Scientists have identified the first genetic variant specifically associated with the risk of a difficult-to-diagnose cancer sub-type accounting for around 10-15 per cent of all breast cancer cases. The largest ever study of the breast cancer sub-type, called invasive lobular carcinoma, gives researchers important clues to the genetic causes of this particular kind of breast cancer, which can be missed through screening. The research, published today (Thursday) in the journal PloS...

2014-04-16 14:11:59

A University of Texas at Arlington physicist working to create a luminescent nanoparticle to use in security-related radiation detection may have instead happened upon an advance in photodynamic cancer therapy. Wei Chen, professor of physics and co-director of UT Arlington's Center for Security Advances Via Applied Nanotechnology, was testing a copper-cysteamine complex created in his lab when he discovered unexplained decreases in its luminescence, or light emitting power, over a...

2014-04-16 12:30:22

Advanced Tumor Modeling for Evaluation of Cancer Therapy Efficacy at the Cellular Level MENLO PARK, Calif., April 16, 2014 /PRNewswire/ -- SRI International has announced the availability of its PDCellX(TM) xenograft tumor model services for testing the activity of potential cancer therapeutics. PDCellX models provide clinically relevant information that allows researchers to evaluate the efficacy of cancer drug candidates in new models that go beyond traditional tumor xenograft...

2014-04-15 12:30:25

New Medical Search Engine Expands Advisory Board to Oversee the Development of its Database LOS ANGELES, April 15, 2014 /PRNewswire/ -- CureCrowd, the first, most advanced medically-guided search engine, announces the expansion of its advisory board with two new members, Drs. George C. Newman, M.D., Ph.D., and Bert A. Weiner, M.D., FACEP (Fellow of the American College of Emergency Physicians). The distinguished neurologist and emergency medical physician will lend endless value and...

2014-04-11 16:21:53

In the news release, Giant Food Triple Winner® Game Continues to Bring Hope in the Fight against Pediatric Brain Tumors, issued 11-Apr-2014 by Giant Food of Landover, Md. over PR Newswire, we are advised by the company that the headline was incorrect on the news release. The headline in the news release should be, "Giant Food Triple Winner® Game Continues to Bring Hope in the Fight against Pediatric Cancer" rather than "Giant Food Triple Winner® Game Continues to Bring Hope in the Fight...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related